NCT00671307View on ClinicalTrials.gov

Ascending Single Dose Study of Rhu-pGelsolin in Patients With Decreased Gelsolin Levels

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

March 31, 2010

Study Completion Date

May 31, 2010

Conditions
Low GelsolinTraumaInfectionBurns
Interventions
DRUG

rhu-pGelsolin

IV formulation of recombinant plasma gelsolin formulated as 10 mg/ml given as a single IV infusion over 1 hour

DRUG

Placebo

Vehicle control given as IV infusion over 1 hour

Trial Locations (1)

Unknown

Queen Mary Hospital; University of Hong Kong, Hong Kong

Sponsors
All Listed Sponsors
lead

Critical Biologics Corporation

INDUSTRY